Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a primary disease of heart muscle that results in fibro fatty replacement of the right ventricle and the sub epi cardial region of the left ventricle. Patients are at high risk for ventricular tachy arrhythmias and sudden death. This is mostly seen in young adults and teenagers.

Materials and Methodology

Place of Study: The study was a prospective observational study on people suffering with Arrhythmogenic Right Ventricular cardiomyopathy and treatment outcomes with clinical pharmacist intervention’’, which was carried out in the ‘Department of Cardiology’ at Narayana Hospitals, Nellore, a 1440 bedded multidisciplinary hospital,

Results: study the maximum number of patients was 75 and the age groups of 10-80 out of which maximum were of age group 21-30 and minimum were  10-20 , the male were more suffered in that maximum were un married and the educational levels of the patients were mostly primary, the hygienic conditions, surroundings and cleanliness were good.

Discussions: The patients recovered from ARVC are very less and some are died. Some are shifted to higher centers and very less recovery. For the recovery of ARVC  ICD’s  are used ,  maximum regular ICD’s  and subcutaneous ICD’s are used and total number of days stayed in the ICU are mostly 14 days for the treatment of ARVC.

Conclusions: Our study concluded that most of the people suffering with ARVC are of due to genetical problems and it is observed on adults and the treatment regimen is not effective and they underwent for the ICD (Implantable Cardioverter Defibrillator).

As a clinical pharmacist and physicians want to work out to find out the treatment and the cause of ARVC.

Keywords: ICD (Implantable Cardioverter Defibrillator), Arrhythmogenic right ventricular cardiomyopathy (ARVC), cardiomyopathy.

1. Curry PVL, Edwards AC, Sowton E: Relation between sites of ventricular tachycardia and underlying ventricular disease: im- plications for therapy. (abstr) Br Heart J 42: 237, 1979
2. Pedersen DH, Zipes DP, Foster PR, Troup PJ: Ventricular tachycardia and ventricular fibrillation in a young population. Circulation 60: 988, 1979.
3. Wei JY, Bulkley BH, Schaeffer AH, Greene HL, Reid PR: Mitral valve prolapse syndrome and recurrent ventricular tachyarrhythmias. Ann Intern Med 89: 6, 1978.
4. Pietras R, Bauerfeind RA, Lam W, Wyndham CRC, Rosen K: Right ventricular function and angiography in patients with right ventricular tachycardia without ischemic heart disease. (abstr) Am J Cardiol 45: 405, 1980.
5. Josephson ME, Horowitz LN, Farshidi A, Kastor JA: Recurrent sustained ventricular tachycardia. I. Mechanism. Circulation 57: 431, 1978.
6. Tenckhoff L, Stamm SJ, Beckwith JB: Sudden death in idio- pathic (congenital) right atrial enlargement. Circulation 40: 227, 1969.
7. Kohne DH, Wellens HJJ: Isolated aneurysmal enlargement of the right atrium. Ned T Geneesk 114: 1175, 1970.
8. Singh A, Katkov H, Zavoral JH, Sane SM, McLoed JD:Congenital aneurysms of the left ventricle. Am Heart J 99: 25, 1980.
9. Bakos ACP: The question of the function of the right ventric-ular myocardium, an experimental study. Circulation 1: 724, 1950.
10. Donald DE, Essex HE: Pressure studies after inactivation of the major portion ot the canine right ventricle. Am 3 Physiol 176: 155, 1954.
11. Forssman 0, Bjorkman G: Absence of the solid part of the right ventricular musculature. Acta Pathol Microbiol Scand (A) 80: 263, 1972.
12. Morand P, Lanfranchi J, Brehier J, Laine JL, Langevin JO, Raynaud R: Le syndrome de Uhl (ventricule droit papyrace). A propos d'une observation clinique avec controle hemo- dynamique, angiographique et isotopique. Semin Hop Paris 48: 571, 1972.
13. Dupont JC, Faton D, Perrin A: Le diagnostic clinique et hemodynamique de la maladie de Uhl chez l'adulte. A propos d'une observation. Lyon Med 231: 247, 1974.
14. Spurrell RAJ, Yates AK, Thornburn CW, Sowton GE, Deuchar DC: Surgical treatment of ventricular tachycardia after epicardial mapping studies. Br Heart J 37: 115, 1975.
15. Cherrier F, Floquet J, Cuilliere M, Neimann JL: Les dysplasies ventriculaires droites. A propos de 7 observations. Arch Mal Coeur 72: 766, 1979.
16. Segall HN: Parchment heart (Osler). Am Heart J 40: 948, 1950.
17. Castleman B, Towne VW: Case record of the Massachusetts General Hospital. N EngI J Med 246: 785, 1952.
18. Miller G, Lowenthal M, Krause S, Rosenbaum P: A saccular outpouching of the right ventricle in a child visualized by angiography. Am J Roentgenol 69: 69, 195.
19. Reeve R, MacDonald D: Partial absence of the right ventric-ular musculature: partial parchment heart. Am J Cardiol 14: 415, 1964.
20. Thiene, G., Nava, A., Corrado, D., Rossi, L. & Pennelli, N. N. Engl. J. Med. 318, 129– 133 (1988).
21. Paul, M., Schulze-Bahr, E., Breithardt, G. & Wichter, T.A. Z. Kardiol. 92, 128–136 (2003).
22. Gerull B, Heuser A, Wichter T, Paul M, Basson CT, McDermott DA, Lerman BB, Markowitz SM, Ellinor PT, MacRae CA, Peters S, Grossmann KS, Drenckhahn J, Michely B, Sasse-Klaassen S, Birchmeier W, Dietz R, Breithardt G, Schulze-Bahr E, Thierfelder L. Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat Genet. 2004;36:1162–1164.

Dr Kanamala Arun Chand Roby

Assistant Professor, Department of Pharmacy Practice, Narayana Pharmacy College- Nellore